Shanghai Curegene Pharmaceutical Co., Ltd.

This early-stage study tests a new drug called CG-0255 against the well-known blood thinner Plavix. The goal is to see how the body processes each drug and how well they work to prevent blood clots. About 136 healthy adults aged 18-55 will take part. This research helps determine…